Edwards Lifesciences Corp (EW) stock saw a modest uptick, ending the day at $74.15 which represents a slight increase of $0.51 or 0.69% from the prior close of $73.64. The stock opened at $73.62 and ...

Edwards Lifesciences Corp. closed $22.48 below its 52-week high ($96.12), which the company reached on March 28th.

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on ...

Bernstein analyst Lee Hambright raised the firm’s price target on Edwards Lifesciences (EW) to $74 from $72 and keeps a Market Perform rating ...

Edwards Lifesciences Corp. closed $22.58 below its 52-week high ($96.12), which the company reached on March 28th.

Edwards Lifesciences Corporation (NYSE:EW) is largely controlled by institutional shareholders who own 85% of the company Institutions' substantial holdings in Edwards Lifesciences implies that they ...

Edwards Lifesciences Co. (NYSE:EW – Get Free Report) has been assigned an average recommendation of “Hold” from the twenty-six brokerages that are covering the stock, Ratings reports. Fifteen equities ...

BofA Securities has recently raised Edwards Lifesciences Corp (EW) stock to Buy rating, as announced on December 16, 2024, according to Finviz. Earlier, on October 11, 2024, Morgan Stanley had resumed ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Edwards Lifesciences (EW – Research Report) on January 6 and set a price ...

Edwards Lifesciences Corporation (EW), headquartered in Irvine, California, is a company that specializes in innovative ...

Edward Lifesciences remains a "Hold" as it trades close to its intrinsic value, despite improved fundamentals and solid third ...

Edwards Lifesciences Co. has a 52 week low of $58.93 and a 52 week high of $96.12. Edwards Lifesciences ( NYSE:EW – Get Free Report ) last announced its earnings results on Thursday, October 24th.